Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV Testing Center in Brazil

Journal of Medical Virology

Volumn 78, Issue 6, 2006, Pages 719-723

  Pereira, G A S ^a   Stefani, M M A ^a   Martelli, C M T ^a   Turchi, M D ^a   Siqueira, E M P ^a   Carneiro, M A S ^a   Martins, R M B ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

HIV HCV co infection; Prevalence; Risk behavior; Subtypes

Indexed keywords

HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BISEXUALITY; BRAZIL; ENVELOPE GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUP SPECIFIC ANTIGEN GENE; HEALTH CARE FACILITY; HEPATITIS C; HEPATITIS C VIRUS; HETERODUPLEX ANALYSIS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; LINE PROBE ASSAY; MAJOR CLINICAL STUDY; MALE; NESTED POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SCREENING TEST; SEROPREVALENCE; SEXUAL BEHAVIOR; SUPERINFECTION; VIRUS DETECTION; VIRUS GENE; VIRUS STRAIN; VIRUS TRANSMISSION; WESTERN BLOTTING;

ADOLESCENT; ADULT; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; ODDS RATIO; PREVALENCE; RISK FACTORS;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33646469592     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20613     Document Type: Article

References (29)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556-562.
2. Alter MJ, Seeff LB, Bacon BR, Thomas DL, Rigsby MO, Di Bisceglie AM. 2004. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med 141:715-717.
3. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T. 1999. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30:1054-1058.
4. Brindeiro RM, Diaz RS, Sabino EC, Morgado MG, Pires IL, Brigido L, Dantas MC, Barreira D, Teixeira PR, Tanuri A. 2003. Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): A survey of chronically infected individuals. AIDS 17:1063-1069.
5. Campiotto S, Pinho JR, Carrilho FJ, Da Silva LC, Souto FJ, Spinelli V, Pereira LM, Coelho HS, Silva AO, Fonseca JC, Rosa H, Lacet CM, Bernardini AP. 2005. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 38:41-49.
6. Chamberland ME, Petersen LR, Munn VP, White CR, Johnson ES, Busch MP, Grindon AJ, Kamel H, Ness PM, Shafer AW, Zeger G. 1994. Human immunodeficiency virus infection among health care workers who donate blood. Ann Intern Med 121:269-273.
7. Des Jarlais DC, Diaz T, Perils T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman SR, Monterroso E, Williams I, Garfein RS. 2003. Variabiliaty in the incidence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol 157:467-471.
8. Ginabreda MG, Yoshida CF, Niel C. 1997. Genomic characterization of Brazilian hepatitis C virus genotypes 1a and 1b. Braz J Med Biol Res 30:339-345.
9. Hadziyannis SJ, Koskinas JS. 2004. Differences in epidemiology, liver disease and treatment response among HCV genotypes. Hepatol Res 29:129-135.
10. HMA Env Subtyping Protocol version 5. Available at http://ubik.microbiol. washington.edu/HMA/index.html. Accessed February 22, 2002.
11. HMA Gag Subtyping Protocol version 3. Available at http://www.itg.be/ microbiol/gagHMA.html. Accessed May 5, 2002.
12. http://www.aids.gov. Accessed on November 10, 2004.
13. Keiserman DR, Both CT, Mattos AA, Remiao J, Alexandre CO, Sherman KE. 2003. Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection. Am J Gastroenterol 98:878-883.
14. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N Engl J Med 345:41-52.
15. Martelli CMT, Turchi MD, Souto FJ, Saez-Alquezar A, Andrade AL, Zicker F. 1999. Anti-HBc testing for blood donations in areas with intermediate hepatitis B endemicity. Rev Panam Salud Publica 6:69-73.
16. Martins RM, Barbosa AP, Oliveira JM, Vanderborght B, Yoshida CF. 2000. Genotype analysis of hepatitis C virus in Brazilian hemophiliacs and blood donors. Vox Sang 78:255.
17. Mendes-Correa MC, Barone AA, Guastini C. 2001. Hepatitis C virus seroprevalence and risk factors among patients with HIV infection. Rev Inst Med Trop Sao Paolo 43:15-19.
18. Ministério da Saúde. 2004. Boletim Epidemiológico- AIDS e DST Ano I no 01.
19. Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda F, Tanaka T, Mishiro S. 1992. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 16:1109-1114.
20. MMWR. 2002. Update: AIDS-United States, 2000. MMWR Morb Mortal Wkly Rep 51:592-595.
21. Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, Shakil O, Fung JJ. 2003. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 9:239-247.
22. Oliveira ML, Bastos FI, Sabino RR, Paetzold U, Schreier E, Pauli G, Yoshida CF. 1999. Distribution of HCV genotypes among different exposure categories in Brazil. Braz J Med Biol Res 32:279-282.
23. Pereira GAS, Stefani MMA, Araujo Filho JA, Souza LCS, Stefani GP, Martelli CMT. 2004. Human immunodeficiency virus type 1 (HIV-1) and Mycobacterium leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort. Am j Trp Med Hyg 71:679-684.
24. Roggendorf M. 2004. Current topics in hepatitis. J Clin Virol 30:5-6.
25. Sherman KE, Rouster SD, Chung RT, Rajicic N. 2002. Hepatitis C Virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 34:831-837.
26. Stefani MM, Pereira GA, Martelli CM, Shindo N, Galvao-Castro B. 2000. Evidence of HIV-1 genetic diversity among pregnant women with AIDS or infected with HIV-1 in Central Brazil. J Acquir Immune Defic Syndr 23:205-207.
27. Turchi MD, Diaz RS, Martelli CM, Sabino EC, Da Silva WP, Filho OF, Laranjeira RR, Busch MP, Castelo A. 2002. Genetic diversity and HIV-1 incidence estimation among cocaine users in Sao Paulo, Brazil. J Acquir Immune Defic Syndr 30:527-532.
28. UNESCO. 2004. Human Development Report. Available at http:// www.unesco.org acessed on April 25, 2005.
29. van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, Rezza G, Broers B, Robertson JR, Brettle RP, McMenamin J, Prins M, Cochrane A, Simmonds P, Coutinho RA, Bruisten S. 2004. Spread of hepatitis C virus among European injection drug users infected with HIV: A phylogenetic analysis. J Infect Dis 189:292-302.